Bedside to bench: The risk of bleeding with parenteral omega-3 lipid emulsion therapy.

[1]  J. Folkman,et al.  Reversal of Parenteral Nutrition–Associated Liver Disease in Two Infants With Short Bowel Syndrome Using Parenteral Fish Oil: Implications for Future Management , 2006, Pediatrics.

[2]  T. To,et al.  Neonatal short bowel syndrome: population-based estimates of incidence and mortality rates. , 2004, Journal of pediatric surgery.

[3]  W. Seeger,et al.  Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. , 2002, American journal of physiology. Heart and circulatory physiology.

[4]  M. Ragaller,et al.  Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery , 2002, British Journal of Nutrition.

[5]  W. Seeger,et al.  Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation. , 1996, Biochemical pharmacology.

[6]  J. Schmee,et al.  Fish Oil, Atherogenesis, and Thrombogenesis a , 1994, Annals of the New York Academy of Sciences.

[7]  R. Ball,et al.  Development and validation of a total parenteral nutrition model in the neonatal piglet. , 1993, The Journal of nutrition.

[8]  D. Churchill,et al.  Effect of n-3 fatty acids from fish oil on hemostasis, blood pressure, and lipid profile of dialysis patients. , 1992, Journal of the American Society of Nephrology : JASN.

[9]  N. Hamasaki,et al.  Beneficial effect of EPA (20:5 n-3 PUFA) on preventing venous thromboembolism: a rat tail thrombosis model experiment. , 2013, Thrombosis research.

[10]  M. Seeberger,et al.  Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. , 2012, Transfusion medicine reviews.